Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
When patients are unable to express their wishes and do not have surrogates or advance directives, which and whose values should inform decision making for them? We discuss ethical complexities of caring for unrepresented patients.
Frances Grimstad, MD, MS and Elizabeth Boskey, PhD, MPH, MSSW, LICSW
Gender-affirming surgery for teens is growing as a field. Norms about who should be involved, to what extent, and for which health decisions are still evolving.
AMA J Ethics. 2020;22(5):E452-457. doi:
10.1001/amajethics.2020.452.
Alice Wong and Dr Joseph Stramondo join us on this special episode of Ethics Talk to discuss how perspectives from the disability community can help us think more powerfully about quality of life, resource allocation, and other ethical challenges arising in pandemics. Transcript available.